Moderacja
Moderacja komentarza
Cristopher: I'm training to be an engineer revatio drug assistance program More recently, it has traded at around $27 to $28 per share, valuing the company at around $15 billion to $16 billion in the private market, Michael Pachter, an analyst at Wedbush Securities, told The News.